JP2023516677A5 - - Google Patents
Info
- Publication number
- JP2023516677A5 JP2023516677A5 JP2022552799A JP2022552799A JP2023516677A5 JP 2023516677 A5 JP2023516677 A5 JP 2023516677A5 JP 2022552799 A JP2022552799 A JP 2022552799A JP 2022552799 A JP2022552799 A JP 2022552799A JP 2023516677 A5 JP2023516677 A5 JP 2023516677A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062985603P | 2020-03-05 | 2020-03-05 | |
| US62/985,603 | 2020-03-05 | ||
| PCT/IB2021/000423 WO2021191689A2 (en) | 2020-03-05 | 2021-03-05 | Treatment of inflammatory diseases with peptides and pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023516677A JP2023516677A (ja) | 2023-04-20 |
| JP2023516677A5 true JP2023516677A5 (enExample) | 2024-04-04 |
Family
ID=77890982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552799A Pending JP2023516677A (ja) | 2020-03-05 | 2021-03-05 | ペプチド及び医薬組成物による炎症性疾患の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230146455A1 (enExample) |
| EP (1) | EP4114430A4 (enExample) |
| JP (1) | JP2023516677A (enExample) |
| KR (1) | KR20220149745A (enExample) |
| CA (1) | CA3170606A1 (enExample) |
| TW (1) | TW202146426A (enExample) |
| WO (1) | WO2021191689A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12037415B2 (en) | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| US12575976B2 (en) | 2021-11-08 | 2026-03-17 | Recker Medical | Urine quantifying bed pad |
| MX2024006997A (es) * | 2021-12-13 | 2024-06-19 | Eyebiokorea Inc | Composicion para el tratamiento de la degeneracion macular que comprende un nuevo peptido. |
| WO2025149851A2 (en) * | 2024-01-12 | 2025-07-17 | Yuyu Pharma, Inc. | Methods for treating inflammatory diseases |
| WO2026049571A1 (ko) * | 2024-08-29 | 2026-03-05 | 루다큐어 주식회사 | 통증 치료용 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| CA2711696C (en) * | 2008-01-09 | 2021-10-26 | Reza Dana | Therapeutic compositions for treatment of ocular inflammatory disorders |
| ES2822289T3 (es) * | 2016-04-08 | 2021-04-30 | Eyebio Korea | Péptido a base de colágeno tipo II alfa-1 para su uso en el tratamiento de la degeneración macular |
| KR101795653B1 (ko) * | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| KR20180074928A (ko) * | 2016-12-26 | 2018-07-04 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 동물 의약품 조성물 |
| US12037415B2 (en) * | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
| TWI865470B (zh) * | 2018-11-14 | 2024-12-11 | 南韓商柳柳製藥股份有限公司 | 治療眼睛疾病之肽及醫藥組合物 |
-
2021
- 2021-03-05 WO PCT/IB2021/000423 patent/WO2021191689A2/en not_active Ceased
- 2021-03-05 CA CA3170606A patent/CA3170606A1/en active Pending
- 2021-03-05 KR KR1020227034521A patent/KR20220149745A/ko not_active Ceased
- 2021-03-05 US US17/908,396 patent/US20230146455A1/en active Pending
- 2021-03-05 TW TW110108016A patent/TW202146426A/zh unknown
- 2021-03-05 EP EP21774671.8A patent/EP4114430A4/en not_active Withdrawn
- 2021-03-05 JP JP2022552799A patent/JP2023516677A/ja active Pending